Drugs · Entity Annotation Prototype (beta)

10,506articles mentioning drugs

58,393drug mentions

9,496distinct drugs extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted drugs

Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.

View all 9,496 drugs on one page

Articles mentioning drugs

10,506 articles · page 47 of 876

PO:08:214 Real-world use of belimumab in childhood-onset SLE in Spain: cross-sectional analysis from a multicentre study (JULES Registry)

lupusscimed · abstract · 2026-03-01 · 15 matching annotations

96.7%

prednisone belimumab BEL BEL-treated cSLE

…rienced an improvement 74.6% had managed to completely withdraw prednisone .77.6% were still on BEL treatment.Conclusions In the Spanish c…

PO:10:269 Analysis of a monocentric case series of patients with systemic lupus erythematosus treated with belimumab for more than 10 years

lupusscimed · abstract · 2026-03-01 · 15 matching annotations

98.3%

prednisone hydroxychloroquine BEL SLEDAI-2K SLE RWE

…llow-up, with a reduction in disease flares and sparing of both prednisone and cDMARDs. Moreover, this case series highlights that BEL mai…

PT7:02 Discordance between SLEDAI-2K and BILAG-2004 disease activity classification leads to divergent treatment decisions under EULAR 2023 recommendations: a post-hoc analysis of anifrolumab trials

lupusscimed · abstract · 2026-03-01 · 15 matching annotations

91.4%

anifrolumab BILAG-2004 SLEDAI-2K SLEDAI TULIP-2 BILAG SLE lupus

…nalysis included the aggregated placebo arms from phase 2 and 3 anifrolumab trials (MUSE, TULIP-1, TULIP-2) in moderate-to-severe SLE. Phys…

S15:02 Dapirolizumab pegol and flare reduction in patients with SLE in a 48-week phase 3 trial: an updated post hoc analysis of alternative definitions of flares that reflect clinical practice

lupusscimed · abstract · 2026-03-01 · 15 matching annotations

95.5%

dapirolizumab pegol DZP prednisone PBO BILAG-2004

…using data from the phase 3 PHOENYCS GO trial ( NCT04294667) of dapirolizumab pegol (DZP).DZP, a novel CD40L inhibitor, consists of a polyethylene …

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors

jitc · abstract · 2026-02-11 · 15 matching annotations

99.3%

ASP9801 pembrolizumab advanced solid tumors

… due to malignant neoplasm progression; none were attributed to ASP9801. One patient in Group B combination safety cohort achieved conf…

Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic

bmjopen · abstract · 2026-02-05 · 15 matching annotations

97.0%

ruxolitinib fostamatinib RUX FOS COVID-19 pneumonia

…Objectives To determine the safety and efficacy of ruxolitinib (RUX) and fostamatinib (FOS) compared with standard of care (SO…

A phase III, randomised, double-blind, multi-dose, placebo- and naproxen-controlled study to evaluate the efficacy and safety of fasinumab in patients with pain due to osteoarthritis of the knee or hip

rmdopen · abstract · 2026-01-16 · 15 matching annotations

99.0%

fasinumab naproxen OA Osteoarthritis

… The safety profile was similar to that previously observed for fasinumab.Trial registration number NCT03161093.…

Telitacicept versus belimumab for the treatment of systemic lupus erythematosus: a network meta-analysis and cost-effectiveness analysis

lupusscimed · abstract · 2026-01-16 · 15 matching annotations

99.3%

belimumab telitacicept SLE systemic lupus erythematosus

…Objectives Both telitacicept and belimumab are approved for treating active systemic lupus erythematosus (…

Mechanistic insights into bupivacaine spread through anisotropic tissue planes and fascial barriers: experimental evidence for interfascial block dynamics

rapm · abstract · 2026-01-07 · 15 matching annotations

99.1%

bupivacaine methylene blue iodinated contrast interfascial plane blocks

…njected compartments. After simulated quadratus lumborum block, bupivacaine was detected in the psoas major (0.7–487.6 µg/g), quadratus lum…

Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia

ejhpharm · abstract · 2025-12-23 · 15 matching annotations

99.7%

ketamine dexmedetomidine lidocaine opioid epidemic pain

…s and develop new therapeutic alternatives. The combined use of ketamine, lidocaine and dexmedetomidine has been studied for opioid-free…

P06 Standardising acute coronary syndrome management: the impact of electronic order sets on prescribing compliance in a tertiary cardiology centre

heartjnl · abstract · 2025-12-08 · 15 matching annotations

98.7%

Aspirin beta-blockers statins Statin ACEi proton pump inhibitors ACE inhibitors PPIs Beta-blocker Acute Coronary Syndrome+1 more

…cribed (%) N = 76 Improvement (%) p-value Significant? (p<0.05) Aspirin 221 (100) 76 (100) 0 - - Beta-blocker 156 (70.6) 69 (90.8) +20.…

Identifying interhospital variation in hyperosmolar hyperglycemic syndrome (HHS) care: development and outcomes of the DEKODE HHS model

bmjdrc · full text · 2025-12-07 · 15 matching annotations

98.3%

Metformin81 Metformin Metformin16 insulin Insulin19 Insulin91 actate Sulfonylureas3 University of Birmingham type 2 diabetes

… (%) None90 (41.3)21 (47.7)0.238 Insulin91 (41.7)19 (43.2)0.481 Metformin81 (37.2)16 (36.4)0.5 Dipeptidyl peptidase-4 inhbitors (DPP4i)47 (…

Browse drugs

All extracted drugs

Articles mentioning drugs